While some studies suggest ATRA might sensitize glioma cells to chemotherapy [22,23], the direct impact of ATRA on MGMT expression in conjunction with stemness marker reduction in GBM models enriched for stem-like properties remains a key area for investigation. The gene discussed is MGMT; the disease is central nervous system cancer.